Karuna Therapeutics's Total Assets for the quarter that ended in Dec. 2023 was $1,336.21 Mil.
During the past 12 months, Karuna Therapeutics's average Total Assets Growth Rate was 86.80% per year.
During the past 3 years, the average Total Assets Growth Rate was 42.60% per year.
During the past 5 years, the average Total Assets Growth Rate was 107.40% per year.
During the past 7 years, Karuna Therapeutics's highest 3-Year average Total Assets Growth Rate was 413.30%. The lowest was 42.60%. And the median was 139.45%.
The historical data trend for Karuna Therapeutics's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Karuna Therapeutics's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Karuna Therapeutics (NAS:KRTX) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Dec. 2023) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Karuna Therapeutics's Asset Turnover for the quarter that ended in Dec. 2023 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Karuna Therapeutics Total Assets Related Terms
Thank you for viewing the detailed overview of Karuna Therapeutics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Karuna Therapeutics (Karuna Therapeutics) Business Description
Karuna Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical needs. Its product candidate, KarXT is an oral modulator of muscarinic receptors that are located both in the central nervous system, or CNS, and various peripheral tissues.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KRTX has been successfully added to your 